US2014235603A1PendingUtilityA1

Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders

46
Assignee: HRA PHARMA LABPriority: Mar 8, 2006Filed: Apr 24, 2014Published: Aug 21, 2014
Est. expiryMar 8, 2026(expired)· nominal 20-yr term from priority
Inventors:Richard Hausknecht
A61P 7/04A61P 35/00A61P 7/06A61P 15/00A61K 31/56A61K 31/567A61K 31/57A61K 31/557
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the treatment of disorders using anti-progestational agents. More specifically, the present invention relates to the treatment of disorders using low doses of anti-progestational agents. Compared to dosages and lengths of treatment taught by the prior art, the described methods, dosing regimens and medications use effective dosages and lengths of treatment that are lower and/or shorter than previously thought possible.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating uterine fibroids in a woman comprising the step of administering to the woman a selective progesterone receptor modulator (SPRM).

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.